Greenwich LifeSciences, Inc. (GLSI)
20.58
+1.88
(+10.05%)
USD |
NASDAQ |
Nov 18, 16:00
20.58
0.00 (0.00%)
After-Hours: 20:00
Greenwich LifeSciences Net Income (Quarterly) : -5.814M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -5.814M |
| June 30, 2026 | -3.949M |
| March 31, 2026 | -5.657M |
| December 31, 2025 | -7.923M |
| September 30, 2025 | -3.711M |
| June 30, 2025 | -3.749M |
| March 31, 2025 | -2.745M |
| December 31, 2024 | -8.040M |
| September 30, 2024 | -2.669M |
| June 30, 2024 | -2.607M |
| March 31, 2024 | -2.473M |
| December 31, 2023 | -2.747M |
| September 30, 2023 | -2.392M |
| June 30, 2023 | -1.628M |
| March 31, 2023 | -2.125M |
| December 31, 2022 | -2.790M |
| Date | Value |
|---|---|
| September 30, 2022 | -2.319M |
| June 30, 2022 | -0.7461M |
| March 31, 2022 | -1.970M |
| December 31, 2021 | -2.361M |
| September 30, 2021 | -0.8631M |
| June 30, 2021 | -0.7497M |
| March 31, 2021 | -0.597M |
| December 31, 2020 | -1.151M |
| September 30, 2020 | -0.2569M |
| June 30, 2020 | -0.2104M |
| March 31, 2020 | -0.2446M |
| December 31, 2019 | -0.3365M |
| September 30, 2019 | -0.336M |
| June 30, 2019 | -2.604M |
| March 31, 2019 | -0.1487M |
| December 31, 2018 | -1.556M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | 1.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | -0.311M |
| BioCryst Pharmaceuticals, Inc. | 37.92M |
| Imunon, Inc. | -3.750M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.814M |
| EPS Diluted (Quarterly) | -0.3961 |
| Enterprise Value | 296.18M |
| Earnings Yield | -7.82% |
| Normalized Earnings Yield | -7.816 |